Nutriomics Logo Nutriomics Retina Logo
  • Home
  • Research
    • WP1 / Progression of obesity and related complications: role of gut microbiota?
    • WP2 / Intestine as a key player in metabolic disorders
    • WP3 / Adipose tissue Remodeling
    • WP4 / Systems’ biology and data integration (transversal WP)
    • WP5 / Translating our fundamental research for the benefit of patients
  • Team
    • Members
    • Workflow
    • History
  • Collabs
  • Cohorts
  • Tools
  • Publications
  • Contact
  • Home
  • Research
    • WP1 / Progression of obesity and related complications: role of gut microbiota?
    • WP2 / Intestine as a key player in metabolic disorders
    • WP3 / Adipose tissue Remodeling
    • WP4 / Systems’ biology and data integration (transversal WP)
    • WP5 / Translating our fundamental research for the benefit of patients
  • Team
    • Members
    • Workflow
    • History
  • Collabs
  • Cohorts
  • Tools
  • Publications
  • Contact

Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes

Home/Posts/Non classé/Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes
Previous Next
Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes

Authors: Genser L, Aguanno D, Soula HA, Dong L, Trystram L, Assmann K, Salem JE, Vaillant JC, Oppert JM, Laugerette F, Michalski MC, Wind P, Rousset M, Brot-Laroche E, Leturque A, Clément K, Thenet S, Poitou C
J. Pathol. 2018 Jul;
PubMed ID: 29984492

Abstract

Obesity and its metabolic complications are characterized by subclinical systemic and tissue inflammation. In rodent models of obesity, inflammation and metabolic impairments are linked with intestinal barrier damage. However, whether intestinal permeability is altered in human obesity remains to be investigated. In a cohort of 122 severely obese and non-obese patients, we analyzed intestinal barrier function combining in vivo and ex vivo investigations. We found tight junction impairments in the jejunal epithelium of obese patients, evidenced by a reduction of occludin and tricellulin. Serum levels of zonulin and LPS binding protein, two markers usually associated with intestinal barrier alterations, were also increased in obese patients. Intestinal permeability per se was assessed in vivo by quantification of urinary lactitol/mannitol (L/M) and measured directly ex vivo on jejunal samples in Ussing chambers. In the fasting condition, L/M ratio and jejunal permeability were not significantly different between obese and non-obese patients, but high jejunal permeability to small molecules (0.4 kDa) was associated with systemic inflammation within the obese cohort. Altogether, these results suggest that intestinal barrier function is subtly compromised in obese patients. We thus tested whether this barrier impairment could be exacerbated by dietary lipids. To this end, we challenged jejunal samples with lipid micelles and showed that a single exposure increased permeability to macromolecules (4 kDa). Jejunal permeability after the lipid load was two-fold higher in obese patients compared to non-obese controls and correlated with systemic and intestinal inflammation. Moreover, lipid-induced permeability was an explicative variable of type 2 diabetes. In conclusion, intestinal barrier defects are present in human severe obesity and exacerbated by a lipid challenge. This paves the way to the development of novel therapeutic approaches to modulate intestinal barrier function or personalize nutrition therapy to decrease lipid-induced jejunal leakage in metabolic diseases. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

By Genser L, Aguanno D, Soula HA, Dong L, Trystram L, Assmann K, Salem JE, Vaillant JC, Oppert JM, Laugerette F, Michalski MC, Wind P, Rousset M, Brot-Laroche E, Leturque A, Clément K, Thenet S, Poitou C| 2018-09-18T15:37:05+00:00 July 18, 2018|

Share This Story, Choose Your Platform!

FacebookTwitterLinkedinRedditTumblrGoogle+PinterestVkEmail

Related Posts

  • Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance

    Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance

    August 18, 2018
  • Popular
  • Recent
  • Prospective assessment and histological analysis of adherent perinephric fat in partial nephrectomies
    March 25, 2017
  • Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss
    March 10, 2017
  • The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass
    July 22, 2017
  • Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance
    August 18, 2018
  • Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes
    July 18, 2018
  • Gut microbiota and obesity: Concepts relevant to clinical care
    March 8, 2018

Recent Posts

  • Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance
  • Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes
  • Gut microbiota and obesity: Concepts relevant to clinical care
  • The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass
  • Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue

Archives

  • Home
  • Research
  • Team
  • Publications
  • Cohorts
  • Tools
  • Contact & Plan
Copyright 2012 - 2017 Nutriomics | All Rights Reserved